Media Releases

Joe Paduda to Discuss Work Comp Drug Formularies at the Sixth Annual Louisiana Workers’ Compensation Educational Conference

The conference will be held January 21-22 in Baton Rouge

Baton Rouge, La. (January 12, 2016) – Like other states battling the opioid epidemic, Louisiana is exploring the concept of a state workers’ compensation formulary. Planners of the Sixth Annual Louisiana Workers’ Compensation Educational Conference invited CompPharma President Joseph Paduda to discuss state workers’ compensation formularies and other approaches to opioid management at the upcoming conference. Continue reading Joe Paduda to Discuss Work Comp Drug Formularies at the Sixth Annual Louisiana Workers’ Compensation Educational Conference


CompPharma’s 12th Annual Survey of Prescription Drug Management in Workers’ Compensation reveals increased drug spend

Maggie Valley, North Carolina (Oct. 6, 2015) – Payers responding to CompPharma’s 12th Annual Survey of Prescription Drug Management in Workers’ Compensation reported an increase of 6.4 percent in their 2014 drug spend.

“This increase is significant, especially in light of last year’s survey showing a 3.8 percent decrease in spend,” said CompPharma’s President Joseph Paduda.

This was the first increase since 2009, when payers reported an increase of 9.4 percent. Respondents cited prescribing behavior, narcotics and the growth in prescriptions for compounds as the main cost drivers. Continue reading CompPharma’s 12th Annual Survey of Prescription Drug Management in Workers’ Compensation reveals increased drug spend


Compounds Pose Emerging Cost Driver in Work Comp Pharmacy, but Physician Dispensing and Opioids Still Major Concerns, According to CompPharma’s 11th Annual Survey of Prescription Drug Management in Workers’ Compensation

Tampa, Fla. (Dec. 16, 2014) – Drug costs still worry workers’ compensation payers, despite relatively flat pharmacy costs, according to the results of CompPharma’s annual survey report of Prescription Drug Management in Workers’ Compensation. The 11th annual report can be found at http://tinyurl.com/CP2014Survey.

Answering the question “How big of a problem are drug costs?” on a scale of 1-5 with 3 being “Drug costs are equally as important at other medical cost issues,” respondents put drug costs at 4.1. A slight increase over the past three-year average of 3.8, it indicated drug costs were more important than other medical cost issues. Respondents also predicted drug costs would be more of problem in the next two years than they are now. Continue reading Compounds Pose Emerging Cost Driver in Work Comp Pharmacy, but Physician Dispensing and Opioids Still Major Concerns, According to CompPharma’s 11th Annual Survey of Prescription Drug Management in Workers’ Compensation


Joe Paduda Recaps Latest Research on Physician Dispensing at North Carolina Workers’ Compensation Educational Conference

Studies show claims with physician dispensed drugs have longer claims duration, poorer outcomes, and higher costs.

Raleigh, N.C. (Sept. 30, 2014) -Worker’s compensation pharmacy expert Joe Paduda, principal of Health Strategy Associates, LLC and president of CompPharma, LLC shares the latest study results on physician dispensing of repackaged prescription drugs at the 19th Annual North Carolina Workers’ Compensation Educational Conference. Scheduled from October 8 through 10, the conference takes place at the Raleigh Convention Center, 500 South Salisbury Street in Raleigh, NC.

Paduda discusses studies showing that physician-dispensed opioids lead to longer treatment durations and indemnity periods, poorer outcomes, and dramatically higher claims costs. Continue reading Joe Paduda Recaps Latest Research on Physician Dispensing at North Carolina Workers’ Compensation Educational Conference


CompPharma Research on Compounded Drugs Questions their Efficacy, Safety and Cost

Tampa, Fla. (April 1, 2014)CompPharma, a consortium of workers’ compensation pharmacy benefit managers, has published results of its research on compounded medications. “Compounding is Confounding Workers’ Compensation” is available here.

“The benefits of compounds are uncertain, and the patient safety issues are profound,” said CompPharma’s President Joseph Paduda. “Insurance companies and other work comp payers are struggling with the increase in compounded drug prescriptions and their high costs. Member PBMs researched the safety, efficacy, pricing, regulation, and reimbursement of compounds to help the industry better understand the possible benefits and address the risks.”

The analysis found no clinical evidence that topical compounds commonly used in workers’ compensation are more effective than commercially available, manufactured drugs. Additionally, the research identified significant patient safety concerns, including inconsistent regulatory oversight, inaccurate dosing in sterile preparations as well as sterility concerns, duplicate drug ingredients and excessive concentrations of drugs in topical compounds. Continue reading CompPharma Research on Compounded Drugs Questions their Efficacy, Safety and Cost


It Costs More for Pharmacies to Dispense Prescriptions for Workers’ Compensation than Medi-Cal

Sacramento, Calif. (Nov. 11, 2013) – A recently released study supports what pharmacists have long suspected: it costs more for California pharmacies to dispense prescriptions to workers’ compensation patients than to the state’s Medi-Cal recipients.

Conducted by MENTORx/PharmAccount, “A Comparison of Personnel Costs to Dispense Workers’ Compensation and Medi-Cal Prescriptions in California Community Pharmacies,” analyzed pharmacies’ personnel-related dispensing costs and bad-debt expenses. “It found expenses are $6 to $9.90 per script higher for workers’ compensation than Medi-Cal,” said Joseph Paduda, president of CompPharma, a consortium of workers’ compensation pharmacy benefit managers requesting the study. Continue reading It Costs More for Pharmacies to Dispense Prescriptions for Workers’ Compensation than Medi-Cal


CompPharma’s Tenth Annual Survey of Prescription Drug Management in Workers’ Compensation Shows Great Gains in Pharmacy Management

TAMPA, FLA. (September 9, 2013) —  Workers’ compensation pharmacy issues barely registered on payers’ radar screens when CompPharma President Joe Paduda, also principal of Health Strategy Associates, started surveying payers about pharmacy costs in 2003.

“Back then, respondents saw costs going up, but didn’t understand why. Cost containment focused on the price per pill and the size of the retail pharmacy network,” Paduda said. “Today utilization, particularly of opioids, physician dispensing and patient safety frame the discussion, and we have witnessed a remarkable increase in sophisticated utilization management and cost-containment strategies.”

These include advanced data analytics, electronic communications, reporting, and innovative drug therapy management. The techniques seem to be paying off since the pharmacy cost inflation rate has dropped 21 percentage points during the last ten years. Continue reading CompPharma’s Tenth Annual Survey of Prescription Drug Management in Workers’ Compensation Shows Great Gains in Pharmacy Management


CompPharma Shares Workers’ Compensation Solutions to Opioid Abuse at the National Rx Drug Abuse Summit

ORLANDO, FLA. (March 19, 2013) —  Representatives from CompPharma’s workers’ compensation pharmacy benefit manager (PBM) member companies will discuss legislative, regulatory and clinical approaches to tackling opioid abuse in workers’ compensation at the National Rx Drug Abuse Summit on April 2 in Orlando.

Even though opioids are not recommended for long-term chronic pain, 24 percent of the work comp pharmacy dollar is spent on opioids (compared to only three percent in group health). “Workers’ Compensation and the Opioid Conundrum: Handling a Painful Challenge in a Pain Focused Marketplace” features PMSI’s Executive Director of Government Affairs Kevin Tribout, Healthesystem’s Director of Compliance Harry Monroe, myMatrixx’s Chief Clinical and Compliance Officer Phil Walls, R.Ph. and Modern Medical’s Director of Clinical Services Robyn Satterfield, Pharm.D. Continue reading CompPharma Shares Workers’ Compensation Solutions to Opioid Abuse at the National Rx Drug Abuse Summit


CompPharma’s Joe Paduda to Moderate “The Tale of Two States” Session at the National Prescription Drug Abuse Summit on April 3

TAMPA, FLA. (February 25, 2013) —  What do Texas and Washington State have in common? Both have seen excellent results from proactive regulatory/legislative efforts to stem the tide of opioid overuse and abuse in their workers’ compensation systems.

Joseph Paduda, president of CompPharma, LLC, will moderate “The Tale of Two States,” at the National Prescription Drug Abuse Summit at the Omni Orlando Resort at Champion’s Gate on April 3, starting at 3 p.m.

Amy Lee, Special Deputy Commissioner for Policy and Research at the Texas Department of Insurance, Division of Workers’ Compensation, will discuss the Texas Closed Formulary, which requires physicians to obtain pre-authorization before prescribing opioids and certain other drugs. The formulary has dramatically reduced the number of prescriptions for opioids. Continue reading CompPharma’s Joe Paduda to Moderate “The Tale of Two States” Session at the National Prescription Drug Abuse Summit on April 3


Opioids and Physician Dispensing of Repackaged Drugs Lead Comp Pharmacy Cost Drivers

According to CompPharma’s 2012 Survey of Prescription Drug Management in Workers’ Compensation

TAMPA, FLA. (January 9, 2013) —  Opioids and physician dispensing of repackaged drugs topped the list of cost drivers in the 2012 Survey of Prescription Drug Management released by CompPharma, LLC, a consortium of workers’ compensation pharmacy benefit managers (WC-PBMs). Joseph Paduda, principal of Health Strategy Associates and president of CompPharma, has been conducting the study for nine consecutive years.

Respondents said opioids were the biggest problem in work comp pharmacy management and most had implemented programs to address opioid overuse and abuse. These programs included nurses conducting specialty reviews, pharmacists contacting treating physicians, physician peer-to-peer contact, urine drug testing, education on proper dosage and monitoring, and increased use of WC-PBM drug utilization, fraud and abuse programs. Continue reading Opioids and Physician Dispensing of Repackaged Drugs Lead Comp Pharmacy Cost Drivers